Lnc-EST885通过与TRAF4相互作用,通过PI3K / AKT通路促进肝细胞癌转移
Shaoliang Zhu1, Gang Wang2, Yuxuan Zhang3
1Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning 530021, China.
长非编码RNA (lncRNA) lnc-EST885通过激活TRAF4/PI3K/AKT通路来促进肝细胞癌 (HCC) 的生长和转移. 高 lnc-EST885表达预测HCC预后不佳,提供一个潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 肝细胞癌 (HCC) 是一种具有全球意义的恶性瘤,具有复杂的分子基础.
- 了解非编码RNA,如长非编码RNA (lncRNAs) 的作用,对于破译HCC病原性至关重要.
研究的目的:
- 研究 lncRNA lnc-EST885 在肝细胞癌的发展和进展中的功能和机制.
- 评估Inc-EST885作为潜在的预后生物标志物和HCC的治疗点.
主要方法:
- 使用基于细胞的测试 (FISH,西部斑块,流动细胞计) 来评估增殖,亡,迁移和上皮细胞-介质细胞过渡 (EMT).
- 采用RNA拉下,质谱 (ESI-FT-ICR-MS) 和RIP-qPCR来识别和验证与lnc-EST885.5的蛋白相互作用.
- 进行了生物信息学分析和体内动物模型,以评估lnc-EST885.5的临床相关性和转移潜力.
主要成果:
- lnc-EST885在HCC组织中表达的显著高于正常组织,与预后不佳相关.
- lnc-EST885促进了HCC细胞的增殖,迁移和EMT,同时抑制了细胞亡,并在体内促进了肺转移.
- 发现lnc-EST885与TRAF4相互作用,激活PI3K/AKT信号通路,从而驱动HCC细胞恶性病变.
结论:
- lnc-EST885在肝细胞癌的发展和进展中起着至关重要的作用.
- lnc-EST885是HCC预后的一个有前途的生物标志物,也是肝癌治疗的潜在治疗标.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
相关概念视频
lncRNA - Long Non-coding RNAs
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
